HydroxychloroquineThird Party Manufacturing in India
Looking to get Hydroxychloroquine manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.
Mechanism of Action
Hydroxychloroquine is a 4-aminoquinoline compound that accumulates in acidic cytoplasmic vacuoles such as lysosomes, where it raises the pH and interferes with antigen processing and presentation. In malaria, it inhibits the polymerization of heme into hemozoin within the Plasmodium parasite, causing toxic accumulation of free heme that kills the parasite. In autoimmune conditions such as rheumatoid arthritis and lupus erythematosus, hydroxychloroquine modulates the immune response by inhibiting toll-like receptor signaling, reducing cytokine production including TNF-alpha and IL-6, and interfering with T-cell activation. This dual mechanism, combining direct antiparasitic activity with immunomodulation, makes it a uniquely versatile therapeutic agent. Unlike chloroquine, hydroxychloroquine has a better safety profile with lower ocular toxicity risk, allowing for longer-term use in chronic autoimmune diseases. It also exhibits antithrombotic and metabolic benefits in lupus patients.
Therapeutic Uses & Indications
Therapeutic Uses
Hydroxychloroquine is prescribed for the treatment of:
- Malaria: Used for prophylaxis and treatment of uncomplicated malaria caused by chloroquine-sensitive Plasmodium species.
- Rheumatoid Arthritis: Disease-modifying antirheumatic drug for managing symptoms and slowing disease progression.
- Systemic Lupus Erythematosus: Reduces lupus flares and prevents organ damage, particularly skin and joint manifestations.
- Cutaneous Lupus: Treats discoid lupus and other forms of skin lupus.
Why Manufacturers Choose Hydroxychloroquine
Hydroxychloroquine has sustained global demand for both antimalarial and rheumatology applications. Indian manufacturers are well-positioned due to established API supply chains and cost-efficient production capabilities. Its inclusion in the WHO Essential Medicines List and consistent demand from PCD franchise networks make it a strategic addition to any third party manufacturing portfolio. The 200mg tablet format is the standard dosage form globally, ensuring straightforward formulation and packaging.
Dosage Forms We Manufacture
Frequently Asked Questions
What is the minimum order quantity for Hydroxychloroquine?
What dosage forms of Hydroxychloroquine can you manufacture?
Are your manufacturing facilities WHO-GMP certified?
Can you manufacture Hydroxychloroquine for export?
What grade standards do you follow for Hydroxychloroquine?
Get Hydroxychloroquine made under your brand
- WHO-GMP certified facilities
- Quote within 24 hours
- MOQ from 1,000 tablets per batch
+91 9689237122 · replies within hours
Our Manufacturing Capabilities
- WHO-GMP Certified Partner Plants
- 25+ years of pharma industry experience
- PCD Franchise with monopoly rights
- Export support across 25+ countries
- Small batch to commercial scale
- Custom formulation development
Packaging Options
Blister pack (Alu-Alu), Strip pack, HDPE bottle. Packaging customized to client brand guidelines.
Start Manufacturing Hydroxychloroquine Today
Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Hydroxychloroquine across all dosage forms. PCD franchise and export orders welcome.

